BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28388534)

  • 1. Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients.
    Zhou S; Fang F; Chen H; Zhang W; Chen Y; Shi Y; Zheng Z; Ma Y; Tang L; Feng J; Zhang Y; Sun L; Chen Y; Liang B; Yu K; Jiang S
    Oncotarget; 2017 Jun; 8(25):40724-40731. PubMed ID: 28388534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of absolute lymphocyte/monocyte ratio, red cell distribution width and neutrophil/ lymphocyte ratio in diffuse large B-cell lymphoma patients.
    Hasan KM; Elmeshhedany AY
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):61-68. PubMed ID: 34933732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.
    Li M; Xia H; Zheng H; Li Y; Liu J; Hu L; Li J; Ding Y; Pu L; Gui Q; Zheng Y; Zhai Z; Xiong S
    BMC Cancer; 2019 Nov; 19(1):1084. PubMed ID: 31711453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy.
    Beltran BE; Paredes S; Castro D; Cotrina E; Sotomayor EM; Castillo JJ
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e551-e557. PubMed ID: 31320254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of hemoglobin to red cell distribution width: an inflammatory predictor of survival in AIDS-related DLBCL.
    Chen J; Wu Y; Zhao H; Ruan G; Qin S
    Front Immunol; 2024; 15():1354325. PubMed ID: 38426083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).
    Bento L; Díaz-López A; Barranco G; Martín-Moreno AM; Baile M; Martín A; Sancho JM; García O; Rodríguez M; Sánchez-Pina JM; Novelli S; Salar A; Bastos M; Rodríguez-Salazar MJ; González de Villambrosia S; Córdoba R; García-Recio M; Martínez-Serra J; Del Campo R; Luzardo H; García D; Hong A; Abrisqueta P; Sastre-Serra J; Roca P; Rodríguez J; Gutiérrez A;
    Br J Haematol; 2020 Mar; 188(6):888-897. PubMed ID: 31782146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.
    Rahchamani M; Sedghi M; Hakimi A; Nejatianfar M; Javaheri T; Tavakoli R; Ahmadi R; Makarem M; Azmi-Naei N; Zahmatkesh Sangani S; Kamandi N; Soleimanian A; Shavaleh R; Foogerdi M; Rahmani K
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1936. PubMed ID: 37997648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
    Troppan KT; Melchardt T; Deutsch A; Schlick K; Stojakovic T; Bullock MD; Reitz D; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Egle A; Pichler M
    Eur J Haematol; 2015 Dec; 95(6):538-44. PubMed ID: 25677782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma.
    Miao Y; Zhou XH; Guo JJ; Sun Q; Shi K; Wu JZ; Zhu HY; Wang L; Fan L; Xu W; Li JY
    Cancer Med; 2019 Jun; 8(6):2751-2758. PubMed ID: 30980510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Go SI; Park MJ; Song HN; Kim HG; Kang MH; Lee HR; Kim Y; Kim RB; Lee SI; Lee GW
    J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):567-576. PubMed ID: 27104110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases.
    Hong JY; Hong ME; Choi MK; Kim YS; Chang W; Maeng CH; Park S; Lee SJ; Do IG; Jo JS; Jung SH; Kim SJ; Ko YH; Kim WS
    Ann Oncol; 2014 Jan; 25(1):182-8. PubMed ID: 24356628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of the Ratio of Peripheral Hemoglobin-to-Red Cell Distribution width on the Prognosis of Patients with Diffuse Large B-cell Lymphoma].
    Dong XY; Tang GF; Chen W; Cao J; Cheng H; Li ZY; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):765-770. PubMed ID: 35680803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
    Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study.
    Periša V; Zibar L; Sinčić-Petričević J; Knezović A; Periša I; Barbić J
    Croat Med J; 2015 Aug; 56(4):334-43. PubMed ID: 26321026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognostic features of 63 HIV-associated diffuse large B-cell lymphoma: a single-center real-world study in China].
    Wang CY; Liu J; Liang XP; Guo BL; Hu RZ; Liu Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):203-208. PubMed ID: 35405777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of Red Blood Cell Distribution Width and Fibrinogen Level for Evaluation of the Therapeutic Efficacy and Prognosis in Patients with Diffuse Large B-Cell Lymphoma].
    Wang X; Wu CY; Zeng PY; Li LL; Ma CC; Xiang X; Li YQ; Chai Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):153-159. PubMed ID: 32027269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):671-9. PubMed ID: 26361646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.